{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:00:53Z","timestamp":1791259253462,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009812","name":"Princess Margaret Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.radonc.2021.02.005","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T04:46:42Z","timestamp":1613537202000},"page":"255-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy"],"prefix":"10.1016","volume":"157","author":[{"given":"Erin T.","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O'Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Persaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolie","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Bratman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.radonc.2021.02.005_b0005","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0010","doi-asserted-by":"crossref","unstructured":"Habbous S, Chu KP, Lau H, et al. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation. CMAJ 2017; 189: E1030\u2013E40.","DOI":"10.1503\/cmaj.161379"},{"key":"10.1016\/j.radonc.2021.02.005_b0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3747\/co.26.4819","article-title":"Human papillomavirus-associated oropharyngeal cancer: review of current evidence and management","volume":"26","author":"You","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.02.005_b0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2012.44.0164","article-title":"Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis","volume":"31","author":"O'Sullivan","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104585","article-title":"Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer","volume":"103","author":"Canavan","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0035","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/cncr.31983","article-title":"Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy","volume":"125","author":"Ng","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.02.005_b0040","unstructured":"National Comprehensive Cancer Network. NCCN guidelines. Head and neck cancers. https:\/\/www.nccn.org\/professionals\/physician_gls\/default.aspx (accessed April 25, 2020."},{"key":"10.1016\/j.radonc.2021.02.005_b0045","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0050","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1017\/S0022215116000396","article-title":"Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines","volume":"130","author":"Lewis-Jones","year":"2016","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.radonc.2021.02.005_b0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2019.1976","article-title":"Factors to consider when contemplating posttreatment surveillance for survivors of HPV-associated oropharyngeal squamous cell carcinoma","author":"Swegal","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2021.02.005_b0060","first-page":"1525","article-title":"Surveillance imaging in HPV-related oropharyngeal cancer","volume":"38","author":"Su","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2021.02.005_b0065","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijrobp.2013.08.049","article-title":"Temporal nodal regression and regional control after primary radiation therapy for N2\u2013N3 head-and-neck cancer stratified by HPV status","volume":"87","author":"Huang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.005_b0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijrobp.2010.08.031","article-title":"Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy","volume":"82","author":"Huang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.02.005_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoto.2019.1934","article-title":"Association of NCCN-recommended posttreatment surveillance with outcomes in patients with HPV-associated oropharyngeal squamous cell carcinoma","author":"Masroor","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2021.02.005_b0080","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.29782","article-title":"Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer","volume":"122","author":"Frakes","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.02.005_b0085","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/cncr.32968","article-title":"Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal","volume":"126","author":"Huang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.02.005_b0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2010.03.015","article-title":"Point-of-care outcome assessment in the cancer clinic: audit of data quality","volume":"95","author":"Wong","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0095","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2021.02.005_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.207.1.9530307","article-title":"Comparison of CT and MR imaging in staging of neck metastases","volume":"207","author":"Curtin","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2021.02.005_b0105","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1586\/14737140.2015.978862","article-title":"Imaging evaluation of lymphadenopathy and patterns of lymph node spread in head and neck cancer","volume":"15","author":"Forghani","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.radonc.2021.02.005_b0110","doi-asserted-by":"crossref","unstructured":"Sananmuang T, Yu E, Su J, et al. Pre- and post-radiotherapy radiologic nodal features and oropharyngeal cancer outcomes. Laryngoscope 2020; Epub ahead of print.","DOI":"10.1002\/lary.29045"},{"key":"10.1016\/j.radonc.2021.02.005_b0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/lary.26268","article-title":"When should surveillance imaging be performed after treatment for head and neck cancer?","volume":"127","author":"Heineman","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2021.02.005_b0120","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1002\/cncr.28831","article-title":"Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer","volume":"120","author":"Garden","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.02.005_b0125","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMoa1514493","article-title":"PET-CT surveillance versus neck dissection in advanced head and neck cancer","volume":"374","author":"Mehanna","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.02.005_b0130","doi-asserted-by":"crossref","unstructured":"Paleri V, Urbano TG, Mehanna H, et al. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130: S161-S9.","DOI":"10.1017\/S002221511600058X"},{"key":"10.1016\/j.radonc.2021.02.005_b0135","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/hed.25513","article-title":"(18) F-FDG PET\/CT for locoregional surveillance following definitive treatment of head and neck cancer: a meta-analysis of reported studies","volume":"41","author":"Wong","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2021.02.005_b0140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12957-015-0481-1","article-title":"Surveillance radiologic imaging after treatment of oropharyngeal cancer: a review","volume":"13","author":"Wang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hed.25425","article-title":"Posttreatment surveillance PET\/CT for HPV-associated oropharyngeal cancer","volume":"41","author":"Corpman","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2021.02.005_b0150","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamaoto.2013.607","article-title":"Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma","volume":"138","author":"Chan","year":"2012","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2021.02.005_b0155","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.oraloncology.2013.12.003","article-title":"Reliability of post-chemoradiotherapy F-18-FDG PET\/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer","volume":"50","author":"Vainshtein","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0160","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.oraloncology.2018.01.023","article-title":"Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial","volume":"78","author":"Wang","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.oraloncology.2018.11.033","article-title":"Utility of a repeat PET\/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy","volume":"88","author":"Liu","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2021.02.005_b0170","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00259-018-3978-3","article-title":"FDG-PET\/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance","volume":"45","author":"Helsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.radonc.2021.02.005_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21170","volume":"21","author":"Mehanna","year":"2017","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.radonc.2021.02.005_b0180","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12967-020-02330-y","article-title":"Circulating HPV16 DNA may complement imaging assessment of early treatment efficacy in patients with HPV-positive oropharyngeal cancer","volume":"18","author":"Rutkowski","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.radonc.2021.02.005_b0185","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.19.02444","article-title":"Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer","volume":"38","author":"Chera","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:17:27Z","timestamp":1759123047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021060540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":37,"alternative-id":["S0167814021060540"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.02.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Head and neck imaging surveillance strategy for HPV-positive oropharyngeal carcinoma following definitive (chemo)radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}